Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Drug Safety
Published in: Drug Safety 9/2012

Open Access 01-09-2012 | Original Research Article

Incidence and Economic Burden of Adverse Drug Reactions among Elderly Patients in Ontario Emergency Departments

A Retrospective Study

Authors: Chen Wu, Chaim M. Bell, Dr Walter P. Wodchis

Published in: Drug Safety | Issue 9/2012

Login to get access

Abstract

Background: The rapid rise in the availability and use of pharmaceutical agents, and particularly polypharmacy, directly increases the risk for patients to experience adverse drug reactions (ADRs). There are few studies on the overall incidence and costs of ADRs.
Objective: The aim of this study was to estimate the incidence and costs of emergency department (ED) visits related to ADRs for patients greater than 65 years of age using administrative data, and to describe risk factors for experiencing severe ADRs.
Methods: We employed a retrospective cohort design based on population-based healthcare administrative clinical databases. Identification of ADR-related ED visits from the administrative database was based on International Classification of Diseases, 10th Revision-Canadian Enhancement (ICD-10-CA) codes for each ED visit. The incidence and costs of ADR-related ED visits and subsequent hospital admissions were estimated for all adults aged 66 years and above for the period April 2003–March 2008. Costs were standardized and reported in 2008 Canadian dollars. Logistic regression was used to detect risk factors for severe ADRs.
Results: Approximately 0.75% of total annual ED visits among adults aged 66 years and above were found to be ADR-related, and among these patients 21.6% were hospitalized. In 2007, the cost of ADR-related visits was $333 per ED visit and $7528 per hospitalization for a total annual cost of $13.6 million in Ontario, or an estimated $35.7 million in Canada. Severe ADRs were associated with sex, age, comorbid disease burden, multiple drugs, multiple pharmacies, newly prescribed drugs, recent ED visit, recent hospitalization and long-term care (LTC) residence.
Conclusions: ADRs are an important public health issue that threaten the safety of drug therapy and results in significant economic burden to the healthcare system. ED visits related to ADRs may be underestimated in retrospective studies using administrative data compared with prospective studies. Further research is needed to better understand the risk of experiencing severe ADRs among LTC residents.
Appendix
Available only for authorised users
Literature
1.
WHO. International drug monitoring: the role of the national centers. World Health Organ Tech Rep Ser 1972; 498: 1–25
2.
Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998 Apr 15; 279(15): 1200–5CrossRef
3.
Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 2002 Dec; 50(12): 1962–8CrossRef
4.
Patel H, Bell D, Molokhia M, et al. Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998–2005. BMC Clin Pharmacol 2007; 7: 9CrossRef
5.
Dormann H, Criegee-Rieck M, Neubert A, et al. Lack of awareness of community-acquired adverse drug reactions upon hospital admission: dimensions and consequences of a dilemma. Drug Saf 2003; 26(5): 353–62CrossRef
6.
Moore N, Lecointre D, Noblet C, et al. Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol 1998 Mar; 45(3): 301–8CrossRef
7.
Leendertse AJ, Visser D, Egberts ACG, et al. The relationship between study characteristics and the prevalence of medication-related hosptializations. Drug Saf 2010; 33(3): 233–44CrossRef
8.
Zed PJ. Drug-related visits to the emergency department. J Pharm Pract 2005 October 1; 18(5): 329–35CrossRef
9.
Lipscombe LL, Gomes T, Levesque LE, et al. Thiazolidinediones and cardiovascular outcomes in older patients with diabetes. JAMA 2007 Dec 12; 298(22): 2634–43CrossRef
10.
Austin PC, Donovan L, Yun L, et al. Comparing clinical and administrative data for profiling hospitals on post-discharge medication use by patients with acute myocardial infarction. Am Heart J 2008 9; 156(3): 595–605CrossRef
11.
Juurlink DN, Gomes T, Ko DT, et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ 2009 Mar 31; 180(7): 713–8CrossRef
12.
Canadian Institute for Health Information. CMG+ tool kit: transitioning to the new CMG+ grouping methodology (and associated health resource indicators) fiscal 2007–2008. Toronto (ON): Canadian Institute for Health In formation, 2007
13.
14.
Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40(5): 373–83CrossRef
15.
Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992 Jun; 45(6): 613–9CrossRef
16.
Statistics Canada. Census Tract (CT) profiles, 2006 census. Catalogue 92-597-XWE. Ottawa (ON): Statistics Canada, 2007
17.
Kutner M, Nachtsheim C, Neter N, Applied linear regression Models. 4th ed. New York: McGraw-Hill Irwin, 2004
18.
Allison P, editor. Logistic regression using the SAS system: theory and application. Cary (NC): SAS Institute, 2001
19.
Forster AJ, Clark HD, Menard A, et al. Adverse events among medical patients after discharge from hospital. CMAJ 2004 Feb 3; 170(3): 345–9PubMedPubMedCentral
20.
Zed PJ, Abu-laban AB, Balen RM, et al. Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study. CMAJ 2008 June 3; 178(12): 1563–9CrossRef
21.
Smith KM, McAdams JW, Frenia ML, et al. Drug-related problems in emergency department patients. Am J Health Syst Pharm 1997 Feb 1; 54(3): 295–8CrossRef
22.
Tafreshi MJ, Melby MJ, Kaback KR, et al. Medication-related visits to the emergency department: a prospective study. Ann Pharmacother 1999 Dec; 33(12): 1252–7CrossRef
23.
Malhotra S, Jain S, Pandhi P. Drug-related visits to the medical emergency department: a prospective study from India. Int J Clin Pharmacol Ther 2001 Jan; 39(1): 12–8CrossRef
24.
Malhotra S, Karan RS, Pandhi P, et al. Drug related medical emergencies in the elderly: role of adverse drug reactions and non-compliance. Postgrad Med J 2001 Nov; 77(913): 703–7CrossRef
25.
Zed PJ, Abu-Laban RB, Balen RM, et al. Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study. CMAJ 2008 Jun 3; 178(12): 1563–9CrossRef
26.
Juurlink D, Preyra C, Croxford R, et al. Canadian Institute for Health Information discharge abstract database: a validation study. Toronto (ON): Institute for Clinical Evaluative Sciences, 2006
27.
Levy AR, O’Brien BJ, Sellors C, et al. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Canadian J Clin Pharmacol 2003; 10(2): 67–71
28.
Institute for Clinical Evaluative Sciences. Improving health care data in Ontario. ICES investigative report. Toronto (ON): Institute for Clinical Evaluative Sciences, 2005
29.
Gautier S, Bachelet H, Bordet R, et al. The cost of adverse drug reactions. Expert Opin Pharmacother 2003; 4(3): 319–26CrossRef
30.
Fattinger K, Roos M, Vergeres P, et al. Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine. Br J Clin Pharmacol 2000 Feb; 49(2): 158–67CrossRef
31.
Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004 Jul 3; 329(7456): 15–9CrossRef
32.
van der Hooft CS, Sturkenboom MC, van Grootheest K, et al. Adverse drug reaction-related hospitalisations: a nationwide study in the Netherlands. Drug Saf 2006; 29(2): 161–8CrossRef
33.
Puche Canas E, Luna Del Castillo JD. Adverse drug reactions in patients visiting a general hospital: a meta-analysis of results. An Med Interna 2007 Dec; 24(12): 574–8PubMed
34.
Mannesse CK, Derkx FH, de Ridder MA, et al. Adverse drug reactions in elderly patients as contributing factor for hospital admission: cross sectional study. BMJ 1997 Oct 25; 315(7115): 1057–8CrossRef
35.
Carbonin P, Pahor M, Bernabei R, et al. Is age an in dependent risk factor of adverse drug reactions in hospi talized medical patients?. J Am Geriatr Soc 1991 Nov; 39(11): 1093–9CrossRef
36.
Bergman U, Wiholm BE. Drug-related problems causing admission to a medical clinic. Eur J Clin Pharmacol 1981; 20(3): 193–200CrossRef
37.
Atkin PA, Shenfield GM. Medication-related adverse reactions and the elderly: a literature review. Adverse Drug React Toxicol Rev 1995; 14(3): 175–91PubMed
38.
Nguyen JK, Fouts MM, Kotabe SE, et al. Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents. Am J Geriatr Pharmacother 2006 Mar; 4(1): 36–41CrossRef
39.
Schnipper JL, Hamann C, Ndumele CD, et al. Effect of an electronic medication reconciliation application and pro cess redesign on potential adverse drug events: a cluster-randomized trial. Arch Intern Med 2009; 169: 771–80CrossRef
40.
Schnipper JL, Kirwin JL, Cotugno MC, et al. Role of pharmacist counselling in preventing adverse drug events after hospitalization. Arch Intern Med 2006; 166: 565–71CrossRef
41.
Rogers G, Alper E, Brunelle D, et al. Reconciling medications at admission: safe practice recommendations and implementation strategies. Jt Comm J Qual Patient Saf. 2006; 32: 37–50PubMed
42.
Waterman AD, Gallagher TH, Garbutt J, et al. Hospitalized patients’ attitudes about and participation in error prevention. J Gen Intern Med 2006; 21: 367–70CrossRef
43.
Ontario Ministry of Health and Long-Term Care. 2006 levels of care classification: provincial summary data. Toronto (ON): Ontario Ministry of Health and Long-Term Care, 2007
44.
Gray SL, Mahoney JE, Blough DK. Adverse drug events in elderly patients receiving home health services following hospital discharge. Ann Pharmacother 1999 Nov; 33(11): 1147–53CrossRef
Metadata
Title
Incidence and Economic Burden of Adverse Drug Reactions among Elderly Patients in Ontario Emergency Departments
A Retrospective Study
Authors
Chen Wu
Chaim M. Bell
Dr Walter P. Wodchis
Publication date
01-09-2012
Publisher
Springer International Publishing
Published in
Drug Safety / Issue 9/2012
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI
https://doi.org/10.1007/BF03261973

Other articles of this Issue 9/2012

Drug Safety 9/2012 Go to the issue

Original Research Article

Drug Fever

Original Research Article

Drug Interactions in Dying Patients

Original Research Article

Methods for Retrospective Detection of Drug Safety Signals and Adverse Events in Electronic General Practice Records

Current Opinion

A Pathway to Improved Prospective Observational Post-Authorization Safety Studies

Current Opinion

Early Investigation of QTc Liability

Short Communication

A Computerized Physician Order Entry Set Designed to Improve Safety of Intravenous Haloperidol Utilization